🇺🇸 FDA
Patent

US 11345715

Biologically active molecules, conjugates thereof, and therapeutic uses

granted A61KA61K31/5365A61K47/68033

Quick answer

US patent 11345715 (Biologically active molecules, conjugates thereof, and therapeutic uses) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/5365, A61K47/68033, A61K47/6849, A61K47/6855